vs
Side-by-side financial comparison of AMICUS THERAPEUTICS, INC. (FOLD) and TREX CO INC (TREX). Click either name above to swap in a different company.
AMICUS THERAPEUTICS, INC. is the larger business by last-quarter revenue ($185.2M vs $161.1M, roughly 1.1× TREX CO INC). TREX CO INC runs the higher net margin — 1.4% vs 0.9%, a 0.5% gap on every dollar of revenue. On growth, AMICUS THERAPEUTICS, INC. posted the faster year-over-year revenue change (23.7% vs -3.9%). TREX CO INC produced more free cash flow last quarter ($22.1M vs $16.0M). Over the past eight quarters, AMICUS THERAPEUTICS, INC.'s revenue compounded faster (29.5% CAGR vs -34.3%).
Amicus Therapeutics, Inc. is a public American biopharmaceutical company based in Philadelphia, Pennsylvania. The company went public in 2007 under the Nasdaq trading symbol FOLD. This followed a 2006 planned offering and subsequent withdrawal, which would have established the trading symbol as AMTX Prior to their IPO, Amicus was funded by a variety of venture capital firms including Radius Ventures, Canaan Partners and New Enterprise Associates.
Trex Company, Inc. is a manufacturer of wood-alternative composite decking, residential railing, and other outdoor items made from recycled materials. Its headquarters is in Winchester, Virginia.
FOLD vs TREX — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $185.2M | $161.1M |
| Net Profit | $1.7M | $2.3M |
| Gross Margin | 85.7% | 30.2% |
| Operating Margin | 8.6% | 2.2% |
| Net Margin | 0.9% | 1.4% |
| Revenue YoY | 23.7% | -3.9% |
| Net Profit YoY | -88.5% | -76.4% |
| EPS (diluted) | $0.00 | $0.03 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $185.2M | $161.1M | ||
| Q3 25 | $169.1M | $285.3M | ||
| Q2 25 | $154.7M | $387.8M | ||
| Q1 25 | $125.2M | $340.0M | ||
| Q4 24 | $149.7M | $167.6M | ||
| Q3 24 | $141.5M | $233.7M | ||
| Q2 24 | $126.7M | $376.5M | ||
| Q1 24 | $110.4M | $373.6M |
| Q4 25 | $1.7M | $2.3M | ||
| Q3 25 | $17.3M | $51.8M | ||
| Q2 25 | $-24.4M | $75.9M | ||
| Q1 25 | $-21.7M | $60.4M | ||
| Q4 24 | $14.7M | $9.8M | ||
| Q3 24 | $-6.7M | $40.6M | ||
| Q2 24 | $-15.7M | $87.0M | ||
| Q1 24 | $-48.4M | $89.1M |
| Q4 25 | 85.7% | 30.2% | ||
| Q3 25 | 88.5% | 40.5% | ||
| Q2 25 | 90.2% | 40.8% | ||
| Q1 25 | 90.7% | 40.5% | ||
| Q4 24 | 90.1% | 32.7% | ||
| Q3 24 | 90.6% | 39.9% | ||
| Q2 24 | 91.1% | 44.7% | ||
| Q1 24 | 87.7% | 45.4% |
| Q4 25 | 8.6% | 2.2% | ||
| Q3 25 | 20.3% | 24.7% | ||
| Q2 25 | -6.1% | 26.4% | ||
| Q1 25 | -6.3% | 24.0% | ||
| Q4 24 | 10.7% | 9.2% | ||
| Q3 24 | 15.3% | 23.2% | ||
| Q2 24 | 11.8% | 31.1% | ||
| Q1 24 | -25.1% | 31.9% |
| Q4 25 | 0.9% | 1.4% | ||
| Q3 25 | 10.2% | 18.1% | ||
| Q2 25 | -15.8% | 19.6% | ||
| Q1 25 | -17.3% | 17.8% | ||
| Q4 24 | 9.8% | 5.8% | ||
| Q3 24 | -4.8% | 17.4% | ||
| Q2 24 | -12.4% | 23.1% | ||
| Q1 24 | -43.9% | 23.8% |
| Q4 25 | $0.00 | $0.03 | ||
| Q3 25 | $0.06 | $0.48 | ||
| Q2 25 | $-0.08 | $0.71 | ||
| Q1 25 | $-0.07 | $0.56 | ||
| Q4 24 | $0.05 | $0.10 | ||
| Q3 24 | $-0.02 | $0.37 | ||
| Q2 24 | $-0.05 | $0.80 | ||
| Q1 24 | $-0.16 | $0.82 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $293.5M | $3.8M |
| Total DebtLower is stronger | $392.7M | — |
| Stockholders' EquityBook value | $274.2M | $1.0B |
| Total Assets | $949.9M | $1.5B |
| Debt / EquityLower = less leverage | 1.43× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $293.5M | $3.8M | ||
| Q3 25 | $263.8M | $11.4M | ||
| Q2 25 | $231.0M | $5.5M | ||
| Q1 25 | $250.6M | $5.0M | ||
| Q4 24 | $249.9M | $1.3M | ||
| Q3 24 | $249.8M | $12.8M | ||
| Q2 24 | $260.1M | $1.2M | ||
| Q1 24 | $239.6M | $3.1M |
| Q4 25 | $392.7M | — | ||
| Q3 25 | $392.0M | — | ||
| Q2 25 | $391.3M | — | ||
| Q1 25 | $390.7M | — | ||
| Q4 24 | $390.1M | — | ||
| Q3 24 | $389.5M | — | ||
| Q2 24 | $388.9M | — | ||
| Q1 24 | $388.4M | — |
| Q4 25 | $274.2M | $1.0B | ||
| Q3 25 | $230.4M | $1.0B | ||
| Q2 25 | $204.3M | $989.3M | ||
| Q1 25 | $193.6M | $910.1M | ||
| Q4 24 | $194.0M | $850.1M | ||
| Q3 24 | $178.8M | $887.9M | ||
| Q2 24 | $132.5M | $894.9M | ||
| Q1 24 | $130.7M | $804.1M |
| Q4 25 | $949.9M | $1.5B | ||
| Q3 25 | $868.8M | $1.5B | ||
| Q2 25 | $815.3M | $1.5B | ||
| Q1 25 | $789.8M | $1.6B | ||
| Q4 24 | $785.0M | $1.3B | ||
| Q3 24 | $786.6M | $1.3B | ||
| Q2 24 | $749.5M | $1.3B | ||
| Q1 24 | $721.8M | $1.3B |
| Q4 25 | 1.43× | — | ||
| Q3 25 | 1.70× | — | ||
| Q2 25 | 1.92× | — | ||
| Q1 25 | 2.02× | — | ||
| Q4 24 | 2.01× | — | ||
| Q3 24 | 2.18× | — | ||
| Q2 24 | 2.93× | — | ||
| Q1 24 | 2.97× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $16.3M | $65.5M |
| Free Cash FlowOCF − Capex | $16.0M | $22.1M |
| FCF MarginFCF / Revenue | 8.6% | 13.7% |
| Capex IntensityCapex / Revenue | 0.2% | 26.9% |
| Cash ConversionOCF / Net Profit | 9.62× | 28.45× |
| TTM Free Cash FlowTrailing 4 quarters | $29.8M | $134.5M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $16.3M | $65.5M | ||
| Q3 25 | $35.7M | $196.9M | ||
| Q2 25 | $-26.5M | $249.8M | ||
| Q1 25 | $7.8M | $-154.0M | ||
| Q4 24 | $-3.9M | $-8.5M | ||
| Q3 24 | $-23.0M | $132.8M | ||
| Q2 24 | $22.7M | $193.7M | ||
| Q1 24 | $-29.7M | $-174.0M |
| Q4 25 | $16.0M | $22.1M | ||
| Q3 25 | $35.3M | $142.9M | ||
| Q2 25 | $-28.9M | $203.0M | ||
| Q1 25 | $7.5M | $-233.5M | ||
| Q4 24 | $-4.2M | $-89.3M | ||
| Q3 24 | $-23.3M | $54.5M | ||
| Q2 24 | $21.6M | $158.2M | ||
| Q1 24 | $-31.5M | $-211.8M |
| Q4 25 | 8.6% | 13.7% | ||
| Q3 25 | 20.9% | 50.1% | ||
| Q2 25 | -18.7% | 52.3% | ||
| Q1 25 | 6.0% | -68.7% | ||
| Q4 24 | -2.8% | -53.3% | ||
| Q3 24 | -16.5% | 23.3% | ||
| Q2 24 | 17.0% | 42.0% | ||
| Q1 24 | -28.5% | -56.7% |
| Q4 25 | 0.2% | 26.9% | ||
| Q3 25 | 0.2% | 18.9% | ||
| Q2 25 | 1.6% | 12.1% | ||
| Q1 25 | 0.2% | 23.4% | ||
| Q4 24 | 0.2% | 48.2% | ||
| Q3 24 | 0.3% | 33.5% | ||
| Q2 24 | 0.9% | 9.4% | ||
| Q1 24 | 1.6% | 10.1% |
| Q4 25 | 9.62× | 28.45× | ||
| Q3 25 | 2.06× | 3.80× | ||
| Q2 25 | — | 3.29× | ||
| Q1 25 | — | -2.55× | ||
| Q4 24 | -0.27× | -0.87× | ||
| Q3 24 | — | 3.27× | ||
| Q2 24 | — | 2.23× | ||
| Q1 24 | — | -1.95× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
FOLD
| Other | $105.8M | 57% |
| Galafold | $64.8M | 35% |
| Pombiliti Opfolda | $14.6M | 8% |
TREX
Segment breakdown not available.
